Nestlé's Currency Headache Masks a Genuine Volume Recovery

Nestlé beats Q1 2026 expectations with 3.5% organic growth and 1.2% real volume gains, as currency headwinds from the strong franc cut reported revenue to CHF 21.3 billion. Shares jump 6% on turnaround hopes.

The Swiss franc continues to take a toll on Nestlé's reported numbers, but beneath the surface, the world's largest food company is finally seeing the momentum shift investors have been waiting for. First-quarter results for 2026 reveal a business that is selling more products rather than simply pushing through price increases — a distinction that has not gone unnoticed by the market.

Organic growth hit 3.5 percent in the period, comfortably ahead of analyst expectations, as the group's internal measure of real volume growth — stripping out pricing entirely — climbed to 1.2 percent. That marks a meaningful departure from recent years, when Nestlé relied heavily on price hikes to prop up its top line. The coffee division provided the strongest tailwind, though a precautionary recall in baby food temporarily weighed on performance. The company says product availability in that category has since normalised.

Reported revenue of 21.3 billion Swiss francs tells a different story, dragged down by negative currency effects of more than nine percent. The strong franc sliced almost six percentage points off the headline figure alone. Yet even that depressed number came in ahead of consensus estimates, underscoring the resilience of the underlying business.

Market rewards the turnaround signal

Investors wasted little time reacting to the operational improvement. Shares on the SIX exchange jumped six percent to trade around 80 francs, pushing the stock above its 100-day moving average for the first time in weeks. The rally came despite the stock remaining slightly in the red on Monday morning at 80.56 francs, hovering nearly five percent below its 50-day line and nursing a modest year-to-date decline.

Analysts at Vontobel described the numbers as early evidence of a sustainable recovery in core operations, while Berenberg upgraded its price target to 100 francs and reiterated a "Buy" rating, citing the quality of the growth. Other houses took a more measured stance: Goldman Sachs sits at 95 francs with a "Buy", Barclays at 86 francs with "Equal Weight", and Deutsche Bank at 82 francs with "Hold".

Portfolio surgery accelerates

Management is using the operational breathing room to push ahead with a strategic overhaul. The premium water business is now being shopped to potential partners, while the entire vitamins and supplements division — home to brands such as Nature's Bounty, Osteo Bi-Flex and Puritan's Pride — is under strategic review and could be sold. The US private-label business in that segment is also on the block.

In Europe, the cost discipline is taking a more human shape. Nestlé is restructuring in France, targeting administrative functions and research centres, with around 180 roles affected. The company aims to minimise actual redundancies through internal transfers and by leaving vacant posts unfilled.

Outlook and dividend in focus

For the full year, management has held its guidance of organic growth between three and four percent. Geopolitical risks and volatile raw material costs remain headwinds, but the group expects an improved operating margin from the second half. Free cash flow is forecast to exceed nine billion francs.

Income-focused investors have their eyes on the payout. Analysts anticipate a modest dividend increase to 3.14 francs per share for the current financial year. The next official milestone comes on 23 July 2026, when Nestlé publishes its first-half results.